Novartis taking full control of Alcon – Novartis AG gained control of Alcon Inc. through the purchase of a 52% stake in the U.S. eyecare company from Nestlé SA in a $28.1 billion deal that is bringing the Swiss drug maker a big step closer to its goal of becoming a global health-care conglomerate. The deal is bringing Novartis’s ownership of Alcon up to 77%, for which it paid Nestlé a total of about $39 billion…more
FDA leaving lumps of coal in the stockings of antibiotics makers (and also being a Scrooge about Pfizer‘s Prevnar). Yes, I know Christmas is over. It just seemed like an apt analogy…!
The patent cliff – some biggies due in 2010.
Rep Certification. Are you trying to figure out how to create a “certification” program for your sales reps, in light of all the state/federal guidelines? We’re keeping our finger on the pulse of this also, and can point you in some helpful directions. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
JUST FOR FUN
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
Connect with Steve Woodruff
Leave a Reply